Innate Defense Mechanism Against Virus Infection Within the Cardiac Myocyte Requiring gp130-STAT3 Signaling
Authors:
- Hideo YasukawaHYHideo Yasukawa
- Eun-Seok JeonEJEun-Seok Jeon
- Dingding XiongDXDingding Xiong
- Andrea DornerADAndrea Dorner
- Mitsuo IwatateMIMitsuo Iwatate
- Miwako NaraMNMiwako Nara
- Hanbing ZhouHZHanbing Zhou
- Daphne Summers-TorresDSDaphne Summers-Torres
- Masahiko HoshijimaMHMasahiko Hoshijima
- Kenneth R. ChienKCKenneth R. Chien
- Akihiko YoshimuraAYAkihiko Yoshimura
- 28 November 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 114 (22) , 2364-2373
Abstract
Background— Little is known about innate immune mechanisms within the cardiac myocyte that determine susceptibility to enterovirus infection, an important cause of myocarditis and subsequent heart failure. Although interferon (IFN) generally plays a key role in innate immunity, ablation of IFN receptors has little or no effect on acute coxsackievirus B3 infection in the heart. Interestingly, gp130-cytokine–mediated stimulation of neonatal ventricular myocytes has a cytoprotective effect against virus infection in culture that can be inhibited by suppressors of cytokine signaling (SOCS)-3, a physiological inhibitor of gp130 signaling that does not affect IFN signaling. Therefore, we hypothesized that inhibition of gp130 signaling by SOCS3 would change cardiac myocyte susceptibility to virus infection without affecting IFN signaling. Methods and Results— We generated cardiac-specific SOCS3 transgenic mice. Despite an intact IFN-mediated antiviral response in adult transgenic myocytes, there was a marked increase in susceptibility to viral infection in the SOCS3 transgenic mouse hearts. This indicated the presence of IFN-independent innate defense mechanisms within the cardiac myocyte. Subsequently, we demonstrated that cardiac-specific gp130-knockout mice also had increased susceptibility to viral infection. Furthermore, we demonstrated that the gp130-mediated increase in survival of infected myocytes occurred through a signal transducers and activators of transcription-3–dependent mechanism that did not affect viral replication. This was accompanied by a persistent expression of full-length dystrophin after coxsackievirus B3 infection. In addition, we found that both SOCS3 transgenic and gp130-deficient mice had a decrease in α-sarcoglycan. Conclusions— SOCS3-mediated regulation of gp130 signaling can affect susceptibility to viral infection in the heart. Increased cardiac cell survival through gp130–signal transducers and activators of transcription-3 signaling appears to play an important role in preserving nondividing cardiac myocytes until specific immune responses begin to clear the virus.Keywords
This publication has 33 references indexed in Scilit:
- Protective Role for Interferon-β in Coxsackievirus B3 InfectionCirculation, 2004
- Alternatively Spliced Soluble Coxsackie-adenovirus Receptors Inhibit Coxsackievirus InfectionJournal of Biological Chemistry, 2004
- Human chromosome 21 gene expression atlas in the mouseNature, 2002
- Target cell defense prevents the development of diabetes after viral infectionNature Immunology, 2002
- Negative Regulation of Cytokine Signaling PathwaysAnnual Review of Immunology, 2000
- SOCS1 Is a Critical Inhibitor of Interferon γ Signaling and Prevents the Potentially Fatal Neonatal Actions of this CytokineCell, 1999
- JAKS AND STATS: Biological ImplicationsAnnual Review of Immunology, 1998
- STATs and Gene RegulationScience, 1997
- Cardiotrophin 1 (CT-1) Inhibition of Cardiac Myocyte Apoptosis via a Mitogen-activated Protein Kinase-dependent PathwayJournal of Biological Chemistry, 1997
- Cytokine receptor signallingNature, 1995